0001494650-23-000103.txt : 20231220
0001494650-23-000103.hdr.sgml : 20231220
20231220122128
ACCESSION NUMBER: 0001494650-23-000103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231215
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahmoud Ramy A
CENTRAL INDEX KEY: 0001718725
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38241
FILM NUMBER: 231500487
MAIL ADDRESS:
STREET 1: 1020 STONY HILL ROAD, SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OptiNose, Inc.
CENTRAL INDEX KEY: 0001494650
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 421771610
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 STONY HILL ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
BUSINESS PHONE: 267-364-3500
MAIL ADDRESS:
STREET 1: 1020 STONY HILL ROAD
STREET 2: SUITE 300
CITY: YARDLEY
STATE: PA
ZIP: 19067
4
1
wk-form4_1703092880.xml
FORM 4
X0508
4
2023-12-15
0
0001494650
OptiNose, Inc.
OPTN
0001718725
Mahmoud Ramy A
C/O OPTINOSE, INC.
1020 STONY HILL ROAD, SUITE 300
YARDLEY
PA
19067
1
1
0
0
Chief Executive Officer
0
Common Stock
2023-12-15
4
A
0
6113
0
A
520842
D
Common Stock
2023-12-18
4
S
0
11114
1.15
D
509728
D
Common Stock
172422
I
By: The Ramy Mahmoud 2014 Trust for Cynthia Mahmoud
Represents the vesting of performance-based restricted stock units (Performance RSUs) granted on March 6, 2020. Fifty percent (50%) of the Performance RSUs vested on June 15, 2022, upon achievement of certain
milestones in connection with the Company's development programs. The balance vests in eight equal quarterly installments, subject to continued service with the Issuer. Each Performance RSU represents the right to
receive one share of common stock of OptiNose, Inc.
Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units under multiple award agreements. This sale is
mandated by the issuer's award agreement under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by
the reporting person.
/s/ Anthony Krick, Attorney-in-Fact
2023-12-19